Angiotensin‐converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients
Authors:
- G PannitteriGPG Pannitteri
- F CampagnaFCF Campagna
- A CandeloroACA Candeloro
- A MontaliAMA Montali
- R CantiniRCR Cantini
- F SeccarecciaFSF Seccareccia
- P P CampaPCP P Campa
- B MarinoBMB Marino
- G RicciGRG Ricci
- 1 June 1998
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 28 (6) , 485-490
Abstract
Background: The deletion (D) allele of the angiotensin‐converting enzyme (ACE) gene has been proposed as a genetic marker of the risk of ischaemic heart disease. However, the relationships between ACE genotypes, the development of coronary atherosclerosis and the occurrence of major coronary events are still controversial.Methods: To investigate whether the ACE I/D (insertion/deletion) polymorphism predicts the risk of coronary stenosis and myocardial infarction (MI), ACE genotypes were determined in 394 consecutive patients who underwent coronary angiography. The presence of coronary artery disease (CAD) (defined by > 50% stenosis) was detected in 236 patients (CAD+); 85 of these individuals had a history of MI. Patients with coronary stenosis < 10% (n = 158) served as controls (CAD−). ACE genotypes were determined by agarose gel sizing after polymerase chain reaction (PCR) amplification.Results: The distribution of ACE genotypes in CAD+ patients was not significantly different from that in CAD− patients (χ2 = 2.63, P < 0.27). After controlling for other coronary risk factors, no significant increase in risk of CAD or MI was found to be associated with the D allele, regardless of whether the D allele was assumed to have a dominant, a co‐dominant or a recessive effect. Similar results were observed in CAD+ patients at lower risk because of low body mass index and apolipoprotein B concentrations. Smoking, apolipoprotein B and history of hypertension were found to be independent predictors of CAD and MI.Conclusion: Our study did not provide evidence of a significant association between ACE genotypes and the development of coronary atherosclerosis. It also failed to support a role of ACE I/D polymorphism in favouring the conversion of coronary stenosis to MI.Keywords
This publication has 28 references indexed in Scilit:
- Gene Polymorphism but not Catalytic Activity of Angiotensin I–Converting Enzyme Is Associated With Coronary Artery Disease and Myocardial Infarction in Low-Risk PatientsCirculation, 1995
- Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic CardiomyopathyCirculation, 1995
- Association of angiotensinogen gene T235 variant with increased risk of coronary heart diseaseThe Lancet, 1995
- Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Myocardial Infarction but Not With Development of Coronary StenosisCirculation, 1995
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian populationAtherosclerosis, 1995
- A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart StudyCirculation, 1995
- Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.Circulation, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculation, 1975